Used in patients with atrial fibrillation or flutter.

Effective in about 60% of patients with flutter and 30% with atrial fibrillation.

Activates a slow inward sodium channel and prolongs action potential duration.

Q-T prolongation and Torsades des Pointes (8% in one clinical trial) may occur.